Back to Results
First PageMeta Content
Technology / Pharmaceutical industry / Alemtuzumab / Email / Genzyme


9th August 2012 Dear Healthcare Provider, Availability of Mabcampath (alemtuzumab) This letter is intended to inform you that Genzyme, a Sanofi company, and its affiliates (hereinafter collectively referred to as the Com
Add to Reading List

Document Date: 2012-08-10 12:32:44

Open Document

File Size: 232,61 KB

Share Result on Facebook

Company

Genzyme / Sanofi company / Clinigen / /

Country

United Kingdom / /

/

/

Organization

MHRA / /

Person

Jasmin Hussein / /

/

Position

Medical Manager / Manager Oncology UK / /

SocialTag